Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history

Table 6 Independent association between Hb and DR

Exposure	Model	Model I	Model II
Hb group	OR (95%CI) P	OR (95%CI) P	OR (95%CI) P
Continuous Hb	0.95 (0.93, 0.96) 0.000**	0.95 (0.94,0.97) 0.000**	0.96 (0.94, 0.97) 0.000**
70–132(g/L)	1	1	1
133–143(g/L)	0.32 (0.17, 0.61) 0.000**	0.38 (0.19, 0.73) 0.004**	0.88 (0.44, 1.74) 0.707
144–157(g/L)	1.61 (0.95, 2.71) 0.076	2.02 (1.12, 3.62) 0.019*	0.27 (0.12, 0.60) 0.001**
158–195(g/L)	0.07 (0.04, 0.13) 0.000**	0.09 (0.05,0.20) 0.000**	0.95 (0.93, 0.97) 0.000**
P for trend	0.000**	0.000**	0.000**

Model: Univariate model; Model I: adjusting for age, gender, and diabetes course; Model II: adjusting for age, gender, diabetes course, hypertension, BMI, Scr, WBC, NLR, PLR, BUN, TG, FPG, HbA1C
Hb hemoglobin, OR odds ratios, CI confidence intervals, BMI body mass index, Scr serum creatinine, WBC white blood cell, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio, BUN blood urea nitrogen, TG triglycerides, FPG fasting plasma glucose, HbA1c glycated hemoglobin A1c
*P < 0.05, **P < 0.01

ISSN: 1758-5996